These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16564782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X.
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP, van Rijswijk MH, Lub-de Hooge MN, Vellenga E, Haagsma EB, Posthumus MD, Jager PL.
    J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN, Lavender JP, Pepys MB.
    N Engl J Med; 1990 Aug 23; 323(8):508-13. PubMed ID: 2377176
    [Abstract] [Full Text] [Related]

  • 6. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN.
    Gut; 1998 May 23; 42(5):727-34. PubMed ID: 9659172
    [Abstract] [Full Text] [Related]

  • 7. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb 23; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 8. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB.
    Lancet; 1991 Aug 10; 338(8763):335-9. PubMed ID: 1677697
    [Abstract] [Full Text] [Related]

  • 9. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN, Aprile C, Capri G, Viganò L, Munzone E, Gianni L, Pepys MB, Merlini G.
    Eur J Nucl Med; 1998 Jul 10; 25(7):701-8. PubMed ID: 9662591
    [Abstract] [Full Text] [Related]

  • 10. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X.
    QJM; 1997 Jan 10; 90(1):45-50. PubMed ID: 9093588
    [Abstract] [Full Text] [Related]

  • 11. Amyloid in endomyocardial biopsies.
    Kieninger B, Eriksson M, Kandolf R, Schnabel PA, Schönland S, Kristen AV, Hegenbart U, Lohse P, Röcken C.
    Virchows Arch; 2010 May 10; 456(5):523-32. PubMed ID: 20376481
    [Abstract] [Full Text] [Related]

  • 12. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
    Shah PL, Gillmore JD, Copley SJ, Collins JV, Wells AU, du Bois RM, Hawkins PN, Nicholson AG.
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun 10; 19(2):134-42. PubMed ID: 12102609
    [Abstract] [Full Text] [Related]

  • 13. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 10; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 14. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN, Myers MJ, Epenetos AA, Caspi D, Pepys MB.
    J Exp Med; 1988 Mar 01; 167(3):903-13. PubMed ID: 3351437
    [Abstract] [Full Text] [Related]

  • 15. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
    Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, Gray RE, Hall MA, Woo P, Lavender JP, Pepys MB.
    Arthritis Rheum; 1993 Jun 01; 36(6):842-51. PubMed ID: 8507227
    [Abstract] [Full Text] [Related]

  • 16. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM, Deveaux M, Duneton O, Foissac-Gegoux P, Dumont A, Duquesnoy B, Marchandise X.
    Nephrologie; 1995 Jun 01; 16(6):419-25. PubMed ID: 8524449
    [Abstract] [Full Text] [Related]

  • 17. Demonstration and classification of amyloidosis in needle biopsies of the kidneys, with special reference to amyloidosis of the AA-type.
    Löfberg H, Thysell H, Westman K, Larsen S, Brun C, Gruic V, Grubb A.
    Acta Pathol Microbiol Immunol Scand A; 1987 Nov 01; 95(6):357-63. PubMed ID: 3120491
    [Abstract] [Full Text] [Related]

  • 18. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN.
    Lancet; 2001 Jul 07; 358(9275):24-9. PubMed ID: 11454373
    [Abstract] [Full Text] [Related]

  • 19. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB, Madhoo S, Pepys MB, Hawkins PN.
    Gastroenterology; 1997 Apr 07; 112(4):1362-5. PubMed ID: 9098022
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis].
    Maulin L, Hachulla E, Facon T, Deveaux M, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Marchandise W.
    Rev Med Interne; 1993 Apr 07; 14(10):962. PubMed ID: 8009058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.